Meningococcal Vaccine 76% Effective for Kids Under 5, Study Says
(MedPage Today) -- Complete vaccination with the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) was found to be effective in the prevention of invasive serogroup B and non-serogroup B disease among children younger...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Children | International Medicine & Public Health | Men | Meningitis | Meningitis Vaccine | Study | Vaccines